BRIEF-EMA Says Looking At Extension Of Novavax COVID Shot For Adolescents

BRIEF-EMA Says Looking At Extension Of Novavax COVID Shot For Adolescents

European Medicines Agency (EMA):

* STARTED EVALUATING AN APPLICATION TO EXTEND THE USE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, TO ADOLESCENTS AGED 12 TO 17 Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.